Contract GS07F031BA
Premier Biotech, Llc · General Services Administration · July 22, 2024
Premier Biotech, Llc was awarded a federal contract by General Services Administration (Federal Acquisition Service) on July 22, 2024 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 11 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on June 11, 2026. If all options are exercised, the contract could reach $2.27 million.
Contract details
- PIID
- GS07F031BA
- Award type
- Fss
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Outerwear, Men'S
- First action
- July 22, 2024
- Latest action
- June 11, 2026
Description
FEDERAL SUPPLY SCHEDULE CONTRACT
Modification timeline
-
June 11, 2026Mod PSA917 · Other Administrative Action$0
-
January 13, 2026Mod AO0039 · Add Subcontracting Plan$0
-
January 5, 2026Mod PA0038 · Other Administrative Action$0
-
December 3, 2025Mod PSA907 · Other Administrative Action$0
-
September 9, 2025Mod PS0037 · Other Administrative Action$0
-
September 9, 2025Mod PSA905 · Other Administrative Action$0
-
July 29, 2025Mod PSA904 · Other Administrative Action$0
-
May 5, 2025Mod PSA897$0
-
September 18, 2024Mod AO0035 · Add Subcontracting Plan$0
-
September 18, 2024Mod AO0034 · Add Subcontracting Plan$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Peeled Group Llc | General Services Administration | June 26, 2026 | $0 |
| Leonardo Us Cyber And Security Solutions, Llc | General Services Administration | June 12, 2026 | $0 |
| Merakai, Llc | General Services Administration | September 9, 2021 | $0 |
| Msab Incorporated | General Services Administration | September 8, 2021 | $0 |
| V & A Incorporated | General Services Administration | June 22, 2011 | $0 |
| Elginex Corp | General Services Administration | June 1, 2011 | $465 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract GS07F031BA?
Contract GS07F031BA is a federal contract awarded to Premier Biotech, Llc by General Services Administration on July 22, 2024 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 11 times since the base award.
Who won contract GS07F031BA?
Premier Biotech, Llc won contract GS07F031BA from General Services Administration.
How much is contract GS07F031BA worth?
Contract GS07F031BA has obligated $0 to date but carries a potential ceiling of $2.27 million if fully funded and all options are exercised.